Monte Rosa Therapeutics Inc
GLUE
$10.52+2.14%
End of day · as of Oct 13, 2026, 2:00 AM ET
Mkt cap
$1.56B
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$123.67M
EPS (FY2025)
N/A
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-31.23%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
Latest reported GLUE revenue for 2025-12-31 was $123.7M. Net income was -$38.6M. Revenue was up 63.5% from 2024-12-31 to 2025-12-31. GLUE currently screens at market cap $1.56B.
Use this GLUE research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full GLUE income, balance, and cash tables.
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company in the Healthcare sector.
Latest cached Monte Rosa Therapeutics Inc (GLUE) revenue for Dec 31, 2025 was $123.7M. Net income was -$38.6M. Statements: https://lician.com/financials/glue
Monte Rosa Therapeutics Inc (GLUE) market capitalization is $1.56B on the latest cached snapshot.
Monte Rosa Therapeutics Inc (GLUE) cached previous close $10.30; day range $10.29 – $10.52; volume 1,833,268. Session quote: https://lician.com/quote/glue
Monte Rosa Therapeutics Inc (GLUE) latest cached earnings event is "GLUE earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached GLUE filing is 8-K · Oct 1, 2026. Filings: https://lician.com/sec/glue